Mirae Asset Global Investments Co. Ltd. Has $249,000 Stake in PetMed Express, Inc. (NASDAQ:PETS)

Mirae Asset Global Investments Co. Ltd. cut its holdings in PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,970 shares of the company's stock after selling 704,577 shares during the period. Mirae Asset Global Investments Co. Ltd. owned about 0.16% of PetMed Express worth $249,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Profit Investment Management LLC lifted its holdings in PetMed Express by 19.3% in the 4th quarter. Profit Investment Management LLC now owns 182,333 shares of the company's stock valued at $1,378,000 after purchasing an additional 29,438 shares in the last quarter. Quadrature Capital Ltd lifted its holdings in shares of PetMed Express by 127.2% during the 3rd quarter. Quadrature Capital Ltd now owns 29,597 shares of the company's stock worth $303,000 after acquiring an additional 16,573 shares during the period. Ancora Advisors LLC purchased a new position in shares of PetMed Express during the 3rd quarter worth about $958,000. Trexquant Investment LP purchased a new position in shares of PetMed Express during the 3rd quarter worth about $554,000. Finally, Numerai GP LLC purchased a new position in shares of PetMed Express during the 3rd quarter worth about $216,000. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

PetMed Express Stock Down 0.7 %

Shares of PETS stock traded down $0.03 during trading hours on Friday, hitting $4.02. 208,399 shares of the company were exchanged, compared to its average volume of 369,725. The firm has a market cap of $85.02 million, a PE ratio of -10.31 and a beta of 0.68. PetMed Express, Inc. has a 1 year low of $3.95 and a 1 year high of $16.18. The firm has a fifty day moving average of $4.70 and a 200 day moving average of $6.47.

PetMed Express (NASDAQ:PETS - Get Free Report) last posted its earnings results on Monday, April 15th. The company reported ($0.10) earnings per share (EPS) for the quarter. The business had revenue of $65.32 million for the quarter. PetMed Express had a negative return on equity of 1.25% and a negative net margin of 2.92%. Analysts expect that PetMed Express, Inc. will post 0.01 earnings per share for the current year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.